Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Assertio Holdings, Inc.ASRT · Entity 37706 | Director | December 05, 2020 | December 07, 2020 |
| Assertio Therapeutics, IncASRT · Entity 149352 | Director · Director, President and CEO | February 12, 2020 | February 12, 2020 |
| ECOLAB INC.ECL · Entity 2954 | Director | March 31, 2025 | April 02, 2025 |
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Assertio Holdings, Inc.
Report date December 05, 2020 · Filed December 07, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 564,239 |
Reported balance
After 2020-12-05 transaction · row 1
1 source rowRow 1 · 2020-12-05 · Exercise / conversion · Acquired 73,529 · Balance 564,239 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2020-12-05 | Direct | 0 |
Reported balance
After 2020-12-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-12-05 · Exercise / conversion · Disposed 73,529 · Balance 0 F1: Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock. F2: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 175,000 |
Reported balance
Holding disclosure · report date 2020-12-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 175,000 |
| Common StockSEC Table I · non-derivative | IndirectBy Child | 3,000 |
Reported balance
Holding disclosure · report date 2020-12-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 3,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock.
F2: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Assertio Therapeutics, Inc
Report date February 12, 2020 · Filed February 12, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 244,739 |
Ending reported balance
After 2020-02-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-02-12 · Exercise / conversion · Acquired 97,412 · Balance 275,747 Row 2 · 2020-02-12 · Tax withholding · Disposed 31,008 · Balance 244,739 F1: Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2022-02-12 | Direct | 194,825 |
Reported balance
After 2020-02-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-02-12 · Exercise / conversion · Disposed 97,412 · Balance 194,825 F2: Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock. F4: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities. F3: One-third of these restricted stock units are scheduled to vest on each of February 12, 2020, 2021 and 2022. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 175,000 |
Reported balance
Holding disclosure · report date 2020-02-12 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 175,000 |
| Common StockSEC Table I · non-derivative | IndirectBy Child | 3,000 |
Reported balance
Holding disclosure · report date 2020-02-12 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 3,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
F2: Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock.
F3: One-third of these restricted stock units are scheduled to vest on each of February 12, 2020, 2021 and 2022.
F4: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
ECOLAB INC.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,741.32 |
Reported balance
After 2025-03-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-03-31 · Grant · Acquired 134.16 · Balance 26,741.32 F1: Includes 72.09 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. |
| Common StockSEC Table I · non-derivative | Direct | 26,865.54 |
Reported balance
After 2025-03-31 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2025-03-31 · Grant · Acquired 124.22 · Balance 26,865.54 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 72.09 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.
ZIMMER BIOMET HOLDINGS, INC.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $89.85 | Direct | 38,077.496 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 306.066 · Balance 38,077.496 F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4: Includes 96.739 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
F4: Includes 96.739 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:19 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 306.066 | $0.00 Strike: $89.85 | $0.00 |
DisclosureSEC source: 0001142083-26-000010 · form4-10022026_081008.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,077.496 Underlying: Common Stock · 306.066 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 96.739 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:22 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 317.369 | $0.00 Strike: $86.65 | $0.00 |
DisclosureSEC source: 0001142083-26-000008 · form4-07022026_080754.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,674.691 Underlying: Common Stock · 317.369 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,517.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001142083-26-000006 · form4-05272026_080517.xml · derivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,382 Underlying: Common Stock · 1,517.274 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 875.35 | $0.00 Strike: $85.68 | $0.00 |
DisclosureSEC source: 0001142083-26-000006 · form4-05272026_080517.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,357.322 Underlying: Common Stock · 875.35 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 106.777 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:17 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 308.711 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001142083-26-000004 · form4-04022026_080403.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,375.195 Underlying: Common Stock · 308.711 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 99.385 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 304.439 | $0.00 Strike: $90.33 | $0.00 |
DisclosureSEC source: 0001142083-26-000002 · form4-01052026_090134.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,967.099 Underlying: Common Stock · 304.439 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 85.437 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 21:17 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 280.326 | $0.00 Strike: $98.10 | $0.00 |
DisclosureSEC source: 0001142083-25-000004 · form4-10022025_091019.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,577.223 Underlying: Common Stock · 280.326 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 90.68 phantom stock units accrued on July 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:56 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 301.833 | $0.00 Strike: $91.11 | $0.00 |
DisclosureSEC source: 0001062993-25-012475 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,206.217 Underlying: Common Stock · 301.833 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:46 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,404.798 | $5.00 | $7,023.99 |
DisclosureSEC source: 0001062993-25-010725 · form4.xml · derivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,864.726 Underlying: Common Stock · 1,404.798 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:46 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 810.46 | $0.00 Strike: $92.54 | $0.00 |
DisclosureSEC source: 0001062993-25-010725 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,904.384 Underlying: Common Stock · 810.46 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 79.853 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:59 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 124.22 | $251.56 | $31,249.03 |
DisclosureSEC source: 0001415889-25-009685 · form4-04022025_080452.xml · nonDerivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,865.54 Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:59 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 134.16 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-009685 · form4-04022025_080452.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,741.32 F1 · balance_after: Includes 72.09 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 244.423 | $0.00 Strike: $112.51 | $0.00 |
DisclosureSEC source: 0001062993-25-006821 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,014.071 Underlying: Common Stock · 244.423 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 72.913 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:56 UTC | ECOLAB INC. ECL · Entity 2954 | Exercise / conversionNon-Employee Stock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $144.02 | $0.00 |
DisclosureSEC source: 0001415889-25-004449 · form4-02182025_090245.xml · derivative · entry 3 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,800 shares Expires 2028-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the Date Exercisable column represents the first vesting date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:56 UTC | ECOLAB INC. ECL · Entity 2954 | SaleCommon Stock | 1,800 | $263.05 | $473,490.00 |
DisclosureSEC source: 0001415889-25-004449 · form4-02182025_090245.xml · nonDerivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,535.07 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:56 UTC | ECOLAB INC. ECL · Entity 2954 | Exercise / conversionCommon Stock | 1,800 | $144.02 | $259,227.00 |
DisclosureSEC source: 0001415889-25-004449 · form4-02182025_090245.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,335.07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 22:06 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 133.18 | $234.64 | $31,249.89 |
DisclosureSEC source: 0001415889-25-000547 · form4-01032025_100147.xml · nonDerivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,535.07 F1 · balance_after: Includes 57.04 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 22:06 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 143.83 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-000547 · form4-01032025_100147.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,344.85 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:10 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 260.096 | $0.00 Strike: $105.73 | $0.00 |
DisclosureSEC source: 0001062993-25-000141 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,696.735 Underlying: Common Stock · 260.096 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 74.036 phantom stock units accrued on October 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:35 UTC | ECOLAB INC. ECL · Entity 2954 | Exercise / conversionNon-Employee Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $125.67 | $0.00 |
DisclosureSEC source: 0001415889-24-026963 · form4-11152024_091104.xml · derivative · entry 3 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2027-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the "Date Exercisable" column represents the first vesting date. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:35 UTC | ECOLAB INC. ECL · Entity 2954 | SaleCommon Stock | 2,000 | $249.81 | $499,622.00 |
DisclosureSEC source: 0001415889-24-026963 · form4-11152024_091104.xml · nonDerivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,201.02 F1 · price: This transaction was executed in multiple trades at prices ranging from $249.790 to $249.830, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:35 UTC | ECOLAB INC. ECL · Entity 2954 | Exercise / conversionCommon Stock | 2,000 | $125.67 | $251,330.00 |
DisclosureSEC source: 0001415889-24-026963 · form4-11152024_091104.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,201.02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:39 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 122.87 | $254.34 | $31,250.39 |
DisclosureSEC source: 0001415889-24-024425 · form4-10022024_081059.xml · nonDerivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,201.02 F1 · balance_after: Includes 59.86 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:39 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 132.7 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024425 · form4-10022024_081059.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,018.29 Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:23 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 255.197 | $0.00 Strike: $107.76 | $0.00 |
DisclosureSEC source: 0001062993-24-017259 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,362.603 Underlying: Common Stock · 255.197 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 70.502 phantom stock units accrued on July 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:51 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 130.84 | $238.84 | $31,249.83 |
DisclosureSEC source: 0001415889-24-018936 · form4-07022024_080756.xml · nonDerivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,885.59 F1 · balance_after: Includes 65.22 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:51 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 141.31 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-018936 · form4-07022024_080756.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,689.53 Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:49 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 253.503 | $0.00 Strike: $108.48 | $0.00 |
DisclosureSEC source: 0001062993-24-013328 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,036.904 Underlying: Common Stock · 253.503 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| May 10, 2024 Filed May 14, 2024 20:54 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,068.991 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010206 · form4.xml · derivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,452.928 Underlying: Common Stock · 1,068.991 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 10, 2024 Filed May 14, 2024 20:54 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 616.726 | $0.00 Strike: $121.61 | $0.00 |
DisclosureSEC source: 0001062993-24-010206 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,783.401 Underlying: Common Stock · 616.726 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 63.349 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:49 UTC | ECOLAB INC. ECL · Entity 2954 | GrantNon-Employee Director Stock Option (Right to Buy) · Derivative | 934 | $0.00 Strike: $228.26 | $0.00 |
DisclosureSEC source: 0001415889-24-012611 · form4-05082024_080538.xml · derivative · entry 6 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 934 Underlying: Common Stock · 934 shares Expires 2034-05-06 F2 · derivative.exercise_date: The option became or will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:49 UTC | ECOLAB INC. ECL · Entity 2954 | Exercise / conversionNon-Employee Stock Option (Right to Buy) · Derivative | 2,300 | $0.00 Strike: $115.08 | $0.00 |
DisclosureSEC source: 0001415889-24-012611 · form4-05082024_080538.xml · derivative · entry 5 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,300 shares Expires 2026-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became or will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:49 UTC | ECOLAB INC. ECL · Entity 2954 | Exercise / conversionNon-Employee Stock Option (Right to Buy) · Derivative | 2,200 | $0.00 Strike: $112.75 | $0.00 |
DisclosureSEC source: 0001415889-24-012611 · form4-05082024_080538.xml · derivative · entry 4 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,200 shares Expires 2025-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became or will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:49 UTC | ECOLAB INC. ECL · Entity 2954 | SaleCommon Stock | 4,500 | $227.52 | $1,023,853.50 |
DisclosureSEC source: 0001415889-24-012611 · form4-05082024_080538.xml · nonDerivative · entry 3 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,548.22 F1 · price: This transaction was executed in multiple trades at prices ranging from $227.51 to $227.60, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:49 UTC | ECOLAB INC. ECL · Entity 2954 | Exercise / conversionCommon Stock | 2,300 | $115.08 | $264,672.50 |
DisclosureSEC source: 0001415889-24-012611 · form4-05082024_080538.xml · nonDerivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,048.22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:49 UTC | ECOLAB INC. ECL · Entity 2954 | Exercise / conversionCommon Stock | 2,200 | $112.75 | $248,039.00 |
DisclosureSEC source: 0001415889-24-012611 · form4-05082024_080538.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,748.22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 21:02 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 135.39 | $230.81 | $31,248.96 |
DisclosureSEC source: 0001415889-24-009804 · form4-04022024_090400.xml · nonDerivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,548.22 F1 · balance_after: Includes 71.34 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 21:02 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 146.23 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-009804 · form4-04022024_090400.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,341.49 Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 21:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 207.156 | $0.00 Strike: $132.75 | $0.00 |
DisclosureSEC source: 0001062993-24-007766 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,103.326 Underlying: Common Stock · 207.156 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 60.334 phantom stock units accrued on January 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 22:04 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 151.03 | $198.63 | $29,999.39 |
DisclosureSEC source: 0001415889-24-000329 · form4-01032024_100131.xml · nonDerivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,195.26 F1 · balance_after: Includes 78.09 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 22:04 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 157.33 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000329 · form4-01032024_100131.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,966.14 Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 23:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 225.743 | $0.00 Strike: $121.82 | $0.00 |
DisclosureSEC source: 0001062993-24-000252 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,835.836 Underlying: Common Stock · 225.743 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 71.990 phantom stock units accrued on October 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. This amount also reflects the deduction of 44.263 units to correct an error in the reporting person's Form 4 filed on October 3, 2023, in which the number of phantom stock units received by the reporting person on September 30, 2023, and the total number of phantom stock units held by the reporting person following that date, were over-reported by 44.263 units. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 21:01 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 176.44 | $170.03 | $30,000.45 |
DisclosureSEC source: 0001415889-23-013904 · form4-10032023_091019.xml · nonDerivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,808.81 F1 · balance_after: Includes 67.77 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 21:01 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 183.79 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-013904 · form4-10032023_091019.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,564.6 Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 20:04 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 287.712 | $0.00 Strike: $112.96 | $0.00 |
DisclosureSEC source: 0001062993-23-018795 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,582.366 Underlying: Common Stock · 287.712 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 53.751 phantom stock units accrued on July 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:31 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | PurchaseCommon Stock | 500 | $114.68 | $57,337.55 |
DisclosureSEC source: 0001062993-23-017116 · form4.xml · nonDerivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,400 Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:31 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | PurchaseCommon Stock | 500 | $116.55 | $58,275.00 |
DisclosureSEC source: 0001062993-23-017116 · form4.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,900 Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:57 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 161.4 | $185.88 | $30,000.23 |
DisclosureSEC source: 0001415889-23-010771 · form4-07052023_080731.xml · nonDerivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,380.81 F1 · balance_after: Includes 76.75 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:57 UTC | ECOLAB INC. ECL · Entity 2954 | GrantCommon Stock | 168.12 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-010771 · form4-07052023_080731.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,142.66 Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:24 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 221.827 | $0.00 Strike: $146.51 | $0.00 |
DisclosureSEC source: 0001062993-23-014477 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,240.903 Underlying: Common Stock · 221.827 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.